Breaking News

Asahi Kasei Launches Sonanos Next-Gen Excipients

Aims to address formulation, drug persistence, and delivery challenges by enabling sustained release and enhanced solubility.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Asahi Kasei excipient

Asahi Kasei, a provider in healthcare materials and technology, is launching two new specialty grades in its Sonanos portfolio. Paid samples are available, and products manufactured in compliance with Good Manufacturing Practice (GMP) are scheduled for sale in 2027. Sonanos is a next-generation excipient designed to improve the formulation of injectable drugs.  With growing global demand for biologics, peptides, and oncology therapies, Sonanos aims to address formulation, drug persistence, an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters